Fortis Healthcare Limited
Fortis Healthcare Limited Fundamental Analysis
Fortis Healthcare Limited (FORTIS.BO) shows moderate financial fundamentals with a PE ratio of 73.21, profit margin of 10.94%, and ROE of 10.59%. The company generates $87.7B in annual revenue with strong year-over-year growth of 12.88%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 53.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze FORTIS.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakFORTIS.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateFORTIS.BO shows balanced valuation metrics.
Growth Score
ExcellentFORTIS.BO delivers strong and consistent growth momentum.
Financial Health Score
ModerateFORTIS.BO shows balanced financial health with some risks.
Profitability Score
WeakFORTIS.BO struggles to sustain strong margins.
Key Financial Metrics
Is FORTIS.BO Expensive or Cheap?
P/E Ratio
FORTIS.BO trades at 73.21 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, FORTIS.BO's PEG of -13.85 indicates potential undervaluation.
Price to Book
The market values Fortis Healthcare Limited at 7.45 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 33.95 times EBITDA. This signals the market has high growth expectations.
How Well Does FORTIS.BO Make Money?
Net Profit Margin
For every $100 in sales, Fortis Healthcare Limited keeps $10.94 as profit after all expenses.
Operating Margin
Core operations generate 23.35 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.59 in profit for every $100 of shareholder equity.
ROA
Fortis Healthcare Limited generates $6.39 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Fortis Healthcare Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Fortis Healthcare Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
FORTIS.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
73.21
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-13.85
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.45
vs 25 benchmark
P/S Ratio
Price to sales ratio
8.01
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.34
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.96
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How FORTIS.BO Stacks Against Its Sector Peers
| Metric | FORTIS.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 73.21 | 29.45 | Worse (Expensive) |
| ROE | 10.59% | 779.00% | Weak |
| Net Margin | 10.94% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.34 | 0.26 | Weak (High Leverage) |
| Current Ratio | 0.96 | 4.65 | Weak Liquidity |
| ROA | 6.39% | -19344.00% (disorted) | Weak |
FORTIS.BO outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Fortis Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
68.16%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
1236.98%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
730.47%
Industry Style: Defensive, Growth, Innovation
High Growth